Clinical Trial Update: A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+ [NA]

View source ↗

Summary

Clinical trial investigating the efficacy and safety of extracorporeal carbon dioxide removal using PrismaLung+ for acute respiratory distress syndrome and acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Respiratory Distress Syndrome

Drugs mentioned

• PrismaLung+

Snippet

Sponsor: Vantive Health LLC | Conditions: Acute Respiratory Distress Syndrome, Acute Kidney Injury | NA | Status: RECRUITING